EDGAR Filing Documents for 0001193125-11-123798

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-11-123798

Filing Date

2011-05-03

Accepted

2011-05-03 15:35:33

Documents

Period of Report

2011-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	596605
2	CONFIRMATION WITH BARCLAYS BANK PLC	dex10278.htm	EX-10.278	162488
3	TWELFTH AMENDMENT TO LEASE AGREEMENT	dex10279.htm	EX-10.279	23089
4	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	dex311.htm	EX-31.1	10032
5	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	dex312.htm	EX-31.2	10038
6	CERTIFICATION OF CEO PURSUANT TO SECTION 1350	dex321.htm	EX-32.1	2795
7	CERTIFICATION OF CFO PURSUANT TO SECTION 1350	dex322.htm	EX-32.2	2804
13	GRAPHIC	g175654g21s24.jpg	GRAPHIC	35817
14	GRAPHIC	g175654g69o07.jpg	GRAPHIC	36112
	Complete submission text file	0001193125-11-123798.txt		2989813

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	ppdi-20110331.xml	EX-101.INS	400223
9	XBRL TAXONOMY EXTENSION SCHEMA	ppdi-20110331.xsd	EX-101.SCH	18123
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	ppdi-20110331_cal.xml	EX-101.CAL	43434
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ppdi-20110331_lab.xml	EX-101.LAB	136989
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ppdi-20110331_pre.xml	EX-101.PRE	81785

Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401

Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081

PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)